<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36232667</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>19</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>26</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>The Potential Connection between Molecular Changes and Biomarkers Related to ALS and the Development and Regeneration of CNS.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">11360</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms231911360</ELocationID><Abstract><AbstractText>Neurodegenerative diseases are one of the greatest medical burdens of the modern age, being mostly incurable and with limited prognostic and diagnostic tools. Amyotrophic lateral sclerosis (ALS) is a fatal, progressive neurodegenerative disease characterized by the loss of motoneurons, with a complex etiology, combining genetic, epigenetic, and environmental causes. The neuroprotective therapeutic approaches are very limited, while the diagnostics rely on clinical examination and the exclusion of other diseases. The recent advancement in the discovery of molecular pathways and gene mutations involved in ALS has deepened the understanding of the disease pathology and opened the possibility for new treatments and diagnostic procedures. Recently, 15 risk loci with distinct genetic architectures and neuron-specific biology were identified as linked to ALS through common and rare variant association analyses. Interestingly, the quantity of related proteins to these genes has been found to change during early postnatal development in mammalian spinal cord tissue (opossum <i>Monodelphis domestica</i>) at the particular time when neuroregeneration stops being possible. Here, we discuss the possibility that the ALS-related genes/proteins could be connected to neuroregeneration and development. Moreover, since the regulation of gene expression in developmental checkpoints is frequently regulated by non-coding RNAs, we propose that studying the changes in the composition and quantity of non-coding RNA molecules, both in ALS patients and in the developing central nervous (CNS) system of the opossum at the time when neuroregeneration ceases, could reveal potential biomarkers useful in ALS prognosis and diagnosis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Glava&#x10d;</LastName><ForeName>Damjan</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-9912-3331</Identifier><AffiliationInfo><Affiliation>Department of Molecular Genetics, Institute of Pathology, Faculty of Medicine, University of Ljubljana, 1000 Ljublana, Slovenia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Human Genetics &amp; Pharmacogenomics, Faculty of Medicine, University of Maribor, 2000 Maribor, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mladini&#x107;</LastName><ForeName>Miranda</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3985-6629</Identifier><AffiliationInfo><Affiliation>Laboratory for Molecular Neurobiology, Department of Biotechnology, University of Rijeka, 51000 Rijeka, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ban</LastName><ForeName>Jelena</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5792-3998</Identifier><AffiliationInfo><Affiliation>Laboratory for Molecular Neurobiology, Department of Biotechnology, University of Rijeka, 51000 Rijeka, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzone</LastName><ForeName>Graciela L</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Instituto de Investigaciones en Medicina Traslacional (IIMT), CONICET-Universidad Austral, Buenos Aires B1629AHJ, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;mano</LastName><ForeName>Cynthia</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-8909-9582</Identifier><AffiliationInfo><Affiliation>Departamento de Ciencias Naturales, Universidad Aut&#xf3;noma Metropolitana Unidad Cuajimalpa, Mexico City 05348, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomljanovi&#x107;</LastName><ForeName>Ivana</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Laboratory for Molecular Neurobiology, Department of Biotechnology, University of Rijeka, 51000 Rijeka, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jezernik</LastName><ForeName>Gregor</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-1110-5345</Identifier><AffiliationInfo><Affiliation>Center for Human Genetics &amp; Pharmacogenomics, Faculty of Medicine, University of Maribor, 2000 Maribor, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ravnik-Glava&#x10d;</LastName><ForeName>Metka</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3716-4215</Identifier><AffiliationInfo><Affiliation>Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P3-0427 and P1-0170</GrantID><Agency>Slovenian Research Agency</Agency><Country/></Grant><Grant><GrantID>IP-2016-06-7060</GrantID><Agency>Croatian Science Foundation</Agency><Country/></Grant><Grant><GrantID>uniri-biomed-18-258-6427, uniri-prirod-18-290-1463 and uniri-sp-biomed-19-50-1560</GrantID><Agency>University of Rijeka</Agency><Country/></Grant><Grant><GrantID>CRP/CRO14-03</GrantID><Agency>International Centre for Genetic Engineering and Biotechnology</Agency><Country/></Grant><Grant><GrantID>FONCYT, PICT-2020-SERIEA-00928</GrantID><Agency>Austral University</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D022661">RNA, Untranslated</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008322" MajorTopicYN="N">Mammals</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022661" MajorTopicYN="N">RNA, Untranslated</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS-related genes</Keyword><Keyword MajorTopicYN="N">CNS development</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">neuroregeneration</Keyword><Keyword MajorTopicYN="N">non-coding RNAs</Keyword><Keyword MajorTopicYN="N">peripheral biomarkers</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>14</Day><Hour>2</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36232667</ArticleId><ArticleId IdType="pmc">PMC9570269</ArticleId><ArticleId IdType="doi">10.3390/ijms231911360</ArticleId><ArticleId IdType="pii">ijms231911360</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Beers D.R., Appel S.H. Immune dysregulation in amyotrophic lateral sclerosis: Mechanisms and emerging therapies. Lancet Neurol. 2019;18:211&#x2013;220. doi: 10.1016/S1474-4422(18)30394-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30394-6</ArticleId><ArticleId IdType="pubmed">30663610</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw P.J. Motor Neurone Disease. BMJ. 1999;318:1118&#x2013;1121. doi: 10.1136/bmj.318.7191.1118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.318.7191.1118</ArticleId><ArticleId IdType="pmc">PMC1115517</ArticleId><ArticleId IdType="pubmed">10213726</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S., Velde C.V., Cleveland D.W. ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors. Neuron. 2006;52:39&#x2013;59. doi: 10.1016/j.neuron.2006.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.09.018</ArticleId><ArticleId IdType="pubmed">17015226</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein J.D. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann. Neurol. 2009;65:S3&#x2013;S9. doi: 10.1002/ana.21543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21543</ArticleId><ArticleId IdType="pubmed">19191304</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2006;351:602&#x2013;611. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., et al. TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis. Science. 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan S., Orrell R.W. Pathogenesis of amyotrophic lateral sclerosis. Br. Med. Bull. 2016;119:87&#x2013;98. doi: 10.1093/bmb/ldw026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bmb/ldw026</ArticleId><ArticleId IdType="pubmed">27450455</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S. Pathophysiology of Neurodegeneration in Familial Amyotrophic Lateral Sclerosis. Curr. Mol. Med. 2009;9:255&#x2013;272. doi: 10.2174/156652409787847173.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156652409787847173</ArticleId><ArticleId IdType="pubmed">19355908</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagani M.R., Gonzalez L.E., Uchitel O.D. Autoimmunity in Amyotrophic Lateral Sclerosis: Past and Present. Neurol. Res. Int. 2011;2011:497080. doi: 10.1155/2011/497080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2011/497080</ArticleId><ArticleId IdType="pmc">PMC3150148</ArticleId><ArticleId IdType="pubmed">21826267</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrov D., Mansfield C., Moussy A., Hermine O. ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment? Front. Aging Neurosci. 2017;9:68. doi: 10.3389/fnagi.2017.00068.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00068</ArticleId><ArticleId IdType="pmc">PMC5360725</ArticleId><ArticleId IdType="pubmed">28382000</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawada H. Clinical efficacy of edaravone for the treatment of amyotrophic lateral sclerosis. Expert Opin. Pharmacother. 2017;18:735&#x2013;738. doi: 10.1080/14656566.2017.1319937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14656566.2017.1319937</ArticleId><ArticleId IdType="pubmed">28406335</ArticleId></ArticleIdList></Reference><Reference><Citation>Amado D.A., Davidson B.L. Gene therapy for ALS: A review. Mol. Ther. 2021;29:3345&#x2013;3358. doi: 10.1016/j.ymthe.2021.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2021.04.008</ArticleId><ArticleId IdType="pmc">PMC8636154</ArticleId><ArticleId IdType="pubmed">33839324</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim G., Gautier O., Tassoni-Tsuchida E., Ma X.R., Gitler A.D. ALS Genetics: Gains, Losses, and Implications for Future Therapies. Neuron. 2020;108:822&#x2013;842. doi: 10.1016/j.neuron.2020.08.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.08.022</ArticleId><ArticleId IdType="pmc">PMC7736125</ArticleId><ArticleId IdType="pubmed">32931756</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan M.C., Vucic S., Talbot K., McDermott C.J., Hardiman O., Shefner J.M., Al-Chalabi A., Huynh W., Cudkowicz M., Talman P., et al. Improving clinical trial outcomes in amyotrophic lateral sclerosis. Nat. Rev. Neurol. 2020;17:104&#x2013;118. doi: 10.1038/s41582-020-00434-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-00434-z</ArticleId><ArticleId IdType="pmc">PMC7747476</ArticleId><ArticleId IdType="pubmed">33340024</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen W., van der Spek R.A.A., Bakker M.K., van Vugt J.J.F.A., Hop P.J., Zwamborn R.A.J., de Klein N., Westra H.-J., Bakker O.B., Deelen P., et al. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology. Nat. Genet. 2021;53:1636&#x2013;1648. doi: 10.1038/s41588-021-00973-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00973-1</ArticleId><ArticleId IdType="pmc">PMC8648564</ArticleId><ArticleId IdType="pubmed">34873335</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomljanovi&#x107; I., Petrovi&#x107; A., Ban J., Mladinic M. Proteomic analysis of opossum Monodelphis domestica spinal cord reveals the changes of proteins related to neurodegenerative diseases during developmental period when neuroregeneration stops being possible. Biochem. Biophys. Res. Commun. 2021;587:85&#x2013;91. doi: 10.1016/j.bbrc.2021.11.078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2021.11.078</ArticleId><ArticleId IdType="pubmed">34864550</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentile G., Morello G., La Cognata V., Guarnaccia M., Conforti F.L., Cavallaro S. Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases. J. Pers. Med. 2022;12:770. doi: 10.3390/jpm12050770.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12050770</ArticleId><ArticleId IdType="pmc">PMC9143965</ArticleId><ArticleId IdType="pubmed">35629192</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravnik-Glava&#x10d; M., Glava&#x10d; D. Circulating RNAs as Potential Biomarkers in Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2020;21:1714. doi: 10.3390/ijms21051714.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21051714</ArticleId><ArticleId IdType="pmc">PMC7084402</ArticleId><ArticleId IdType="pubmed">32138249</ArticleId></ArticleIdList></Reference><Reference><Citation>Leblond C.S., Kaneb H.M., Dion P.A., Rouleau G.A. Dissection of genetic factors associated with amyotrophic lateral sclerosis. Exp. Neurol. 2014;262:91&#x2013;101. doi: 10.1016/j.expneurol.2014.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2014.04.013</ArticleId><ArticleId IdType="pubmed">24780888</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H.X., Chen W., Hong S.T., Boycott K.M., Gorrie G.H., Siddique N., Yang Y., Fecto F., Shi Y., Zhai H., et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature. 2011;477:211&#x2013;215. doi: 10.1038/nature10353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10353</ArticleId><ArticleId IdType="pmc">PMC3169705</ArticleId><ArticleId IdType="pubmed">21857683</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddique T., Pericak-Vance M.A., Brooks B.R., Roos R.P., Hung W.-Y., Antel J.P., Munsat T.L., Phillips K., Warner K., Speer M., et al. Linkage analysis in familial amyotrophic lateral sclerosis. Neurology. 1989;39:919. doi: 10.1212/WNL.39.7.919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.39.7.919</ArticleId><ArticleId IdType="pubmed">2739919</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O&#x2019;Regan J.P., Deng H.-X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T.J., Jr., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., et al. Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Rogelj B., Hortob&#xe1;gyi T., De Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., et al. Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6. Science. 2009;323:1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Valdmanis P., Dion P., Spiegelman D., McConkey B.J., Velde C.V., Bouchard J.-P., Lacomblez L., Pochigaeva K., Salachas F., et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 2008;40:572&#x2013;574. doi: 10.1038/ng.132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.132</ArticleId><ArticleId IdType="pubmed">18372902</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Deerlin V.M., Leverenz J.B., Bekris L.M., Bird T.D., Yuan W., Elman L.B., Clay D., Wood E.M., Chen-Plotkin A.S., Martinez-Lage M., et al. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: A genetic and histopathological analysis. Lancet Neurol. 2008;7:409&#x2013;416. doi: 10.1016/S1474-4422(08)70071-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(08)70071-1</ArticleId><ArticleId IdType="pmc">PMC3546119</ArticleId><ArticleId IdType="pubmed">18396105</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Majounie E., Waite A., Simon-Sa&#xe1;nchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., et al. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Millecamps S., Boill&#xe9;e S., Le Ber I., Seilhean D., Teyssou E., Giraudeau M., Moigneu C., Vandenberghe N., Danel-Brunaud V., Corcia P., et al. Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes. J. Med. Genet. 2012;49:258&#x2013;263. doi: 10.1136/jmedgenet-2011-100699.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmedgenet-2011-100699</ArticleId><ArticleId IdType="pubmed">22499346</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijesekera L.C., Leigh P.N. Amyotrophic lateral sclerosis. Orphanet J. Rare Dis. 2009;4:3. doi: 10.1186/1750-1172-4-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-4-3</ArticleId><ArticleId IdType="pmc">PMC2656493</ArticleId><ArticleId IdType="pubmed">19192301</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen P.M., Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: What do we really know? Nat. Rev. Neurol. 2011;7:603&#x2013;615. doi: 10.1038/nrneurol.2011.150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.150</ArticleId><ArticleId IdType="pubmed">21989245</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Chio A., Traynor B.J. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2013;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuji S. The Neurogenomics View of Neurological Diseases. JAMA Neurol. 2013;70:689&#x2013;694. doi: 10.1001/jamaneurol.2013.734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2013.734</ArticleId><ArticleId IdType="pubmed">23571861</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T.M., Alberman E., Swash M. Comparison of sporadic and familial disease amongst 580 cases of motor neuron disease. J. Neurol. Neurosurg. Psychiatry. 1988;51:778&#x2013;784. doi: 10.1136/jnnp.51.6.778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.51.6.778</ArticleId><ArticleId IdType="pmc">PMC1033147</ArticleId><ArticleId IdType="pubmed">3404186</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong M., Hudson A., Alvord W. Familial Amyotrophic Lateral Sclerosis, 1850-1989: A Statistical Analysis of the World Literature. Can. J. Neurol. Sci. 1991;18:45&#x2013;58. doi: 10.1017/S0317167100031280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0317167100031280</ArticleId><ArticleId IdType="pubmed">2036615</ArticleId></ArticleIdList></Reference><Reference><Citation>Liscic R.M., Grinberg L., Zidar J., Gitcho M.A., Cairns N.J. ALS and FTLD: Two faces of TDP-43 proteinopathy. Eur. J. Neurol. 2008;15:772&#x2013;780. doi: 10.1111/j.1468-1331.2008.02195.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2008.02195.x</ArticleId><ArticleId IdType="pmc">PMC2801606</ArticleId><ArticleId IdType="pubmed">18684309</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne S.C., Walsh C., Lynch C., Bede P., Elamin M., Kenna K., McLaughlin R., Hardiman O. Rate of familial amyotrophic lateral sclerosis: A systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry. 2010;82:623&#x2013;627. doi: 10.1136/jnnp.2010.224501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.224501</ArticleId><ArticleId IdType="pubmed">21047878</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerami C., Scarpini E., Cappa S., Galimberti D. Frontotemporal lobar degeneration: Current knowledge and future challenges. J. Neurol. 2012;259:2278&#x2013;2286. doi: 10.1007/s00415-012-6507-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-012-6507-5</ArticleId><ArticleId IdType="pubmed">22532172</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruyama H., Morino H., Ito H., Izumi Y., Kato H., Watanabe Y., Kinoshita Y., Kamada M., Nodera H., Suzuki H., et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature. 2010;465:223&#x2013;226. doi: 10.1038/nature08971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08971</ArticleId><ArticleId IdType="pubmed">20428114</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson J.O., Mandrioli J., Benatar M., Abramzon Y., Van Deerlin V.M., Trojanowski J.Q., Gibbs J.R., Brunetti M., Gronka S., Wuu J., et al. Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS. Neuron. 2010;68:857&#x2013;864. doi: 10.1016/j.neuron.2010.11.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.11.036</ArticleId><ArticleId IdType="pmc">PMC3032425</ArticleId><ArticleId IdType="pubmed">21145000</ArticleId></ArticleIdList></Reference><Reference><Citation>Koppers M., Groen E.J., van Vught P.W., van Rheenen W., Witteveen E., van Es M.A., Pasterkamp R.J., Berg L.H.V.D., Veldink J.H. Screening for rare variants in the coding region of ALS-associated genes at 9p21.2 and 19p13.3. Neurobiol. Aging. 2013;34:1518.e5&#x2013;1518.e7. doi: 10.1016/j.neurobiolaging.2012.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.09.018</ArticleId><ArticleId IdType="pubmed">23141412</ArticleId></ArticleIdList></Reference><Reference><Citation>Fecto F., Yan J., Vemula S.P., Liu E., Yang Y., Chen W., Zheng J.G., Shi Y., Siddique N., Arrat H., et al. SQSTM1 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis. Arch. Neurol. 2011;68:1440&#x2013;1446. doi: 10.1001/archneurol.2011.250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2011.250</ArticleId><ArticleId IdType="pubmed">22084127</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow C.Y., Landers J.E., Bergren S.K., Sapp P.C., Grant A.E., Jones J.M., Everett L., Lenk G.M., McKenna-Yasek D.M., Weisman L.S., et al. Deleterious Variants of FIG4, a Phosphoinositide Phosphatase, in Patients with ALS. Am. J. Hum. Genet. 2009;84:85&#x2013;88. doi: 10.1016/j.ajhg.2008.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2008.12.010</ArticleId><ArticleId IdType="pmc">PMC2668033</ArticleId><ArticleId IdType="pubmed">19118816</ArticleId></ArticleIdList></Reference><Reference><Citation>Elden A.C., Kim H.-J., Hart M.P., Chen-Plotkin A.S., Johnson B.S., Fang X., Armakola M., Geser F., Greene R., Lu M.M., et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010;466:1069&#x2013;1075. doi: 10.1038/nature09320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09320</ArticleId><ArticleId IdType="pmc">PMC2965417</ArticleId><ArticleId IdType="pubmed">20740007</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell J., Paul P., Chen H.-J., Morris A., Payling M., Falchi M., Habgood J., Panoutsou S., Winkler S., Tisato V., et al. Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase. Proc. Natl. Acad. Sci. USA. 2010;107:7556&#x2013;7561. doi: 10.1073/pnas.0914128107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0914128107</ArticleId><ArticleId IdType="pmc">PMC2867752</ArticleId><ArticleId IdType="pubmed">20368421</ArticleId></ArticleIdList></Reference><Reference><Citation>Orlacchio A., Babalini C., Borreca A., Patrono C., Massa R., Basaran S., Munhoz R.P., Rogaeva E.A., St George-Hyslop P.H., Bernardi G., et al. SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis. Brain. 2010;133:591&#x2013;598. doi: 10.1093/brain/awp325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp325</ArticleId><ArticleId IdType="pmc">PMC2822627</ArticleId><ArticleId IdType="pubmed">20110243</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C.-H., Fallini C., Ticozzi N., Keagle P.J., Sapp P.C., Piotrowska K., Lowe P., Koppers M., McKenna-Yasek D., Baron D.M., et al. Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature. 2012;488:499&#x2013;503. doi: 10.1038/nature11280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11280</ArticleId><ArticleId IdType="pmc">PMC3575525</ArticleId><ArticleId IdType="pubmed">22801503</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura A.L., Mitne-Neto M., Silva H.C., Richieri-Costa A., Middleton S., Cascio D., Kok F., Oliveira J.R., Gillingwater T., Webb J., et al. A Mutation in the Vesicle-Trafficking Protein VAPB Causes Late-Onset Spinal Muscular Atrophy and Amyotrophic Lateral Sclerosis. Am. J. Hum. Genet. 2004;75:822&#x2013;831. doi: 10.1086/425287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/425287</ArticleId><ArticleId IdType="pmc">PMC1182111</ArticleId><ArticleId IdType="pubmed">15372378</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Hentati A., Deng H.-X., Dabbagh O., Sasaki T., Hirano M., Hung W.-Y., Ouahchi K., Yan J., Azim A.C., et al. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat. Genet. 2001;29:160&#x2013;165. doi: 10.1038/ng1001-160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1001-160</ArticleId><ArticleId IdType="pubmed">11586297</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.-Z., Bennett C.L., Huynh H.M., Blair I.P., Puls I., Irobi J., Dierick I., Abel A., Kennerson M.L., Rabin B.A., et al. DNA/RNA Helicase Gene Mutations in a Form of Juvenile Amyotrophic Lateral Sclerosis (ALS4) Am. J. Hum. Genet. 2004;74:1128&#x2013;1135. doi: 10.1086/421054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/421054</ArticleId><ArticleId IdType="pmc">PMC1182077</ArticleId><ArticleId IdType="pubmed">15106121</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenway M.J., Andersen P.M., Russ C., Ennis S., Cashman S., Donaghy C., Patterson V., Swingler R., Kieran D., Prehn J., et al. ANG mutations segregate with familial and &#x2018;sporadic&#x2019; amyotrophic lateral sclerosis. Nat. Genet. 2006;38:411&#x2013;413. doi: 10.1038/ng1742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1742</ArticleId><ArticleId IdType="pubmed">16501576</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A., Wieland T., Richter B., Ruf W.P., Schaeffer V., M&#xfc;ller K., Marroquin N., Nordin F., H&#xfc;bers A., Weydt P., et al. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat. Neurosci. 2015;18:631&#x2013;636. doi: 10.1038/nn.4000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4000</ArticleId><ArticleId IdType="pubmed">25803835</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D., Yilmaz R., M&#xfc;ller K., Grehl T., Petri S., Meyer T., Grosskreutz J., Weydt P., Ruf W., Neuwirth C., et al. Hot-spot KIF5A mutations cause familial ALS. Brain. 2018;141:688&#x2013;697. doi: 10.1093/brain/awx370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx370</ArticleId><ArticleId IdType="pmc">PMC5837483</ArticleId><ArticleId IdType="pubmed">29342275</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A., Kenna K.P., Renton A.E., Ticozzi N., Faghri F., Chia R., Dominov J.A., Kenna B.J., Nalls M.A., Keagle P., et al. Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron. 2018;97:1268&#x2013;1283.e6. doi: 10.1016/j.neuron.2018.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.02.027</ArticleId><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen W., Shatunov A., Dekker A.M., McLaughlin R.L., Diekstra F.P., Pulit S.L., van der Spek R.A.A., V&#xf5;sa U., de Jong S., Robinson M.R., et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat. Genet. 2016;48:1043&#x2013;1048. doi: 10.1038/ng.3622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3622</ArticleId><ArticleId IdType="pmc">PMC5556360</ArticleId><ArticleId IdType="pubmed">27455348</ArticleId></ArticleIdList></Reference><Reference><Citation>Morahan J.M., Yu B., Trent R.J., Pamphlett R. A genome-wide analysis of brain DNA methylation identifies new candidate genes for sporadic amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2009;10:418&#x2013;429. doi: 10.3109/17482960802635397.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802635397</ArticleId><ArticleId IdType="pubmed">19922134</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Romero C., Hur J., Bender D.E., Delaney C.E., Cataldo M.D., Smith A.L., Yung R., Ruden D.M., Callaghan B.C., Feldman E.L. Identification of Epigenetically Altered Genes in Sporadic Amyotrophic Lateral Sclerosis. PLoS ONE. 2012;7:e52672. doi: 10.1371/journal.pone.0052672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052672</ArticleId><ArticleId IdType="pmc">PMC3530456</ArticleId><ArticleId IdType="pubmed">23300739</ArticleId></ArticleIdList></Reference><Reference><Citation>Xi Z., Zinman L., Moreno D., Schymick J., Liang Y., Sato C., Zheng Y., Ghani M., Dib S., Keith J., et al. Hypermethylation of the CpG Island Near the G4C2 Repeat in ALS with a C9orf72 Expansion. Am. J. Hum. Genet. 2013;92:981&#x2013;989. doi: 10.1016/j.ajhg.2013.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2013.04.017</ArticleId><ArticleId IdType="pmc">PMC3675239</ArticleId><ArticleId IdType="pubmed">23731538</ArticleId></ArticleIdList></Reference><Reference><Citation>Chestnut B.A., Chang Q., Price A., Lesuisse C., Wong M., Martin L.J. Epigenetic Regulation of Motor Neuron Cell Death through DNA Methylation. J. Neurosci. 2011;31:16619&#x2013;16636. doi: 10.1523/JNEUROSCI.1639-11.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1639-11.2011</ArticleId><ArticleId IdType="pmc">PMC3238138</ArticleId><ArticleId IdType="pubmed">22090490</ArticleId></ArticleIdList></Reference><Reference><Citation>Doroszkiewicz J., Groblewska M., Mroczko B. Molecular Biomarkers and Their Implications for the Early Diagnosis of Selected Neurodegenerative Diseases. Int. J. Mol. Sci. 2022;23:4610. doi: 10.3390/ijms23094610.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23094610</ArticleId><ArticleId IdType="pmc">PMC9100918</ArticleId><ArticleId IdType="pubmed">35563001</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W., Guo L., Li M., Wei C., Li S., Xu R. The pathogenesis of amyotrophic lateral sclerosis: Mitochondrial dysfunction, protein misfolding and epigenetics. Brain Res. 2022;1786:147904. doi: 10.1016/j.brainres.2022.147904.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2022.147904</ArticleId><ArticleId IdType="pubmed">35390335</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S., Yu X., Wang M., Meng Y., Song D., Yang H., Wang D., Bi J., Xu S. Long Non-coding RNAs in Pathogenesis of Neurodegenerative Diseases. Front. Cell Dev. Biol. 2021;9:719247. doi: 10.3389/fcell.2021.719247.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.719247</ArticleId><ArticleId IdType="pmc">PMC8435612</ArticleId><ArticleId IdType="pubmed">34527672</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartel D.P. Metazoan MicroRNAs. Cell. 2018;173:20&#x2013;51. doi: 10.1016/j.cell.2018.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.006</ArticleId><ArticleId IdType="pmc">PMC6091663</ArticleId><ArticleId IdType="pubmed">29570994</ArticleId></ArticleIdList></Reference><Reference><Citation>Kocerha J., Kouri N., Baker M., Finch N., DeJesus-Hernandez M., Gonzalez J., Chidamparam K., A Josephs K., Boeve B.F., Graff-Radford N.R., et al. Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations. BMC Genom. 2011;12:527. doi: 10.1186/1471-2164-12-527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2164-12-527</ArticleId><ArticleId IdType="pmc">PMC3229715</ArticleId><ArticleId IdType="pubmed">22032330</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Wei Q., Chen X., Li C., Cao B., Ou R., Hadano S., Shang H.-F. Aberration of miRNAs Expression in Leukocytes from Sporadic Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci. 2016;9:69. doi: 10.3389/fnmol.2016.00069.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2016.00069</ArticleId><ArticleId IdType="pmc">PMC4987348</ArticleId><ArticleId IdType="pubmed">27582688</ArticleId></ArticleIdList></Reference><Reference><Citation>Waller R., Goodall E.F., Milo M., Cooper-Knock J., Da Costa M., Hobson E., Kazoka M., Wollff H., Heath P.R., Shaw P.J., et al. Serum miRNAs miR-206, 143&#x2013;3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS) Neurobiol. Aging. 2017;55:123&#x2013;131. doi: 10.1016/j.neurobiolaging.2017.03.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.03.027</ArticleId><ArticleId IdType="pmc">PMC5455071</ArticleId><ArticleId IdType="pubmed">28454844</ArticleId></ArticleIdList></Reference><Reference><Citation>Matamala J.M., Arias-Carrasco R., Sanchez C., Uhrig M., Bargsted L., Matus S., Maracaja-Coutinho V., Abarzua S., van Zundert B., Verdugo R., et al. Genome-wide circulating microRNA expression profiling reveals potential biomarkers for amyotrophic lateral sclerosis. Neurobiol. Aging. 2018;64:123&#x2013;138. doi: 10.1016/j.neurobiolaging.2017.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.12.020</ArticleId><ArticleId IdType="pubmed">29458840</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricci C., Marzocchi C., Battistini S. MicroRNAs as Biomarkers in Amyotrophic Lateral Sclerosis. Cells. 2018;7:219. doi: 10.3390/cells7110219.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells7110219</ArticleId><ArticleId IdType="pmc">PMC6262636</ArticleId><ArticleId IdType="pubmed">30463376</ArticleId></ArticleIdList></Reference><Reference><Citation>Joilin G., Leigh P.N., Newbury S.F., Hafezparast M. An Overview of MicroRNAs as Biomarkers of ALS. Front. Neurol. 2019;10:186. doi: 10.3389/fneur.2019.00186.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00186</ArticleId><ArticleId IdType="pmc">PMC6416171</ArticleId><ArticleId IdType="pubmed">30899244</ArticleId></ArticleIdList></Reference><Reference><Citation>Laneve P., Tollis P., Caffarelli E. RNA Deregulation in Amyotrophic Lateral Sclerosis: The Noncoding Perspective. Int. J. Mol. Sci. 2021;22:10285. doi: 10.3390/ijms221910285.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms221910285</ArticleId><ArticleId IdType="pmc">PMC8508793</ArticleId><ArticleId IdType="pubmed">34638636</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T.P.N., Kumar M., Fedele E., Bonanno G., Bonifacino T. MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases. Int. J. Mol. Sci. 2022;23:4718. doi: 10.3390/ijms23094718.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23094718</ArticleId><ArticleId IdType="pmc">PMC9104163</ArticleId><ArticleId IdType="pubmed">35563107</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Zhou F., Guan Y., Meng F., Zhao Z., Su Q., Bao W., Wang X., Zhao J., Huo Z., et al. The Biogenesis of miRNAs and Their Role in the Development of Amyotrophic Lateral Sclerosis. Cells. 2022;11:572. doi: 10.3390/cells11030572.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11030572</ArticleId><ArticleId IdType="pmc">PMC8833997</ArticleId><ArticleId IdType="pubmed">35159383</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan P., Su W., Zhuo Y. The Role of Long Noncoding RNAs in Neurodegenerative Diseases. Mol. Neurobiol. 2016;54:2012&#x2013;2021. doi: 10.1007/s12035-016-9793-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-016-9793-6</ArticleId><ArticleId IdType="pubmed">26910817</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagliardi S., Pandini C., Garofalo M., Bordoni M., Pansarasa O., Cereda C. Long non coding RNAs and ALS: Still much to do. Non-Coding RNA Res. 2018;3:226&#x2013;231. doi: 10.1016/j.ncrna.2018.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncrna.2018.11.004</ArticleId><ArticleId IdType="pmc">PMC6260474</ArticleId><ArticleId IdType="pubmed">30533570</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagliardi S., Zucca S., Pandini C., Diamanti L., Bordoni M., Sproviero D., Arigoni M., Olivero M., Pansarasa O., Ceroni M., et al. Long non-coding and coding RNAs characterization in Peripheral Blood Mononuclear Cells and Spinal Cord from Amyotrophic Lateral Sclerosis patients. Sci. Rep. 2018;8:2378. doi: 10.1038/s41598-018-20679-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-20679-5</ArticleId><ArticleId IdType="pmc">PMC5799454</ArticleId><ArticleId IdType="pubmed">29402919</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki H., Shibagaki Y., Hattori S., Matsuoka M. C9-ALS/FTD-linked proline&#x2013;arginine dipeptide repeat protein associates with paraspeckle components and increases paraspeckle formation. Cell Death Dis. 2019;10:1&#x2013;16. doi: 10.1038/s41419-019-1983-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-1983-5</ArticleId><ArticleId IdType="pmc">PMC6776546</ArticleId><ArticleId IdType="pubmed">31582731</ArticleId></ArticleIdList></Reference><Reference><Citation>Vangoor V.R., Gomes-Duarte A., Pasterkamp R.J. Long non-coding RNAs in motor neuron development and disease. J. Neurochem. 2020;156:777&#x2013;801. doi: 10.1111/jnc.15198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15198</ArticleId><ArticleId IdType="pmc">PMC8048821</ArticleId><ArticleId IdType="pubmed">32970857</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y., Pang D., Li C., Gu X., Chen Y., Ou R., Wei Q., Shang H. The expression discrepancy and characteristics of long non-coding RNAs in peripheral blood leukocytes from amyotrophic lateral sclerosis patients. Mol. Neurobiol. 2022;59:3678&#x2013;3689. doi: 10.1007/s12035-022-02789-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-022-02789-4</ArticleId><ArticleId IdType="pubmed">35364800</ArticleId></ArticleIdList></Reference><Reference><Citation>Varadarajan S.G., Hunyara J.L., Hamilton N.R., Kolodkin A.L., Huberman A.D. Central nervous system regeneration. Cell. 2022;185:77&#x2013;94. doi: 10.1016/j.cell.2021.10.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.10.029</ArticleId><ArticleId IdType="pubmed">34995518</ArticleId></ArticleIdList></Reference><Reference><Citation>Mladinic M., Muller K.J., Nicholls J.G. Central nervous system regeneration: From leech to opossum. J. Physiol. 2009;587:2775&#x2013;2782. doi: 10.1113/jphysiol.2009.169938.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2009.169938</ArticleId><ArticleId IdType="pmc">PMC2718237</ArticleId><ArticleId IdType="pubmed">19525562</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholls J., Saunders N. Regeneration of immature mammalian spinal cord after injury. Trends Neurosci. 1996;19:229&#x2013;234. doi: 10.1016/0166-2236(96)10021-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0166-2236(96)10021-7</ArticleId><ArticleId IdType="pubmed">8761958</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholls J.G., Stewart R.R., Erulkar S.D., Saunders N. Reflexes, fictive respiration and cell division in the brain and spinal cord of the newborn opossum, Monodelphis domestica, isolated and maintained in vitro. J. Exp. Biol. 1990;152:1&#x2013;15. doi: 10.1242/jeb.152.1.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jeb.152.1.1</ArticleId><ArticleId IdType="pubmed">2230634</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran A.P., Warren P.M., Silver J. The Biology of Regeneration Failure and Success after Spinal Cord Injury. Physiol. Rev. 2018;98:881&#x2013;917. doi: 10.1152/physrev.00017.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00017.2017</ArticleId><ArticleId IdType="pmc">PMC5966716</ArticleId><ArticleId IdType="pubmed">29513146</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardoso-Moreira M., Halbert J., Valloton D., Velten B., Chen C., Shao Y., Liechti A., Ascen&#xe7;&#xe3;o K., Rummel C., Ovchinnikova S., et al. Gene expression across mammalian organ development. Nature. 2019;571:505&#x2013;509. doi: 10.1038/s41586-019-1338-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1338-5</ArticleId><ArticleId IdType="pmc">PMC6658352</ArticleId><ArticleId IdType="pubmed">31243369</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z.M., Bandtlow C.E., Eurlkar S.D., Schwab M.E., Nicholls J.G. The Critical Period for Repair of CNS of Neonatal Opossum (Monodelphis domestica) in Culture: Correlation with Development of Glial Cells, Myelin and Growth-inhibitory Molecules. Eur. J. Neurosci. 1995;7:2119&#x2013;2129. doi: 10.1111/j.1460-9568.1995.tb00634.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.1995.tb00634.x</ArticleId><ArticleId IdType="pubmed">8542069</ArticleId></ArticleIdList></Reference><Reference><Citation>Mladinic M., Wintzer M., Del Bel E., Casseler C., Lazarevic D., Crovella S., Gustincich S., Cattaneo A., Nicholls J. Differential Expression of Genes at Stages When Regeneration Can and Cannot Occur after Injury to Immature Mammalian Spinal Cord. Cell. Mol. Neurobiol. 2005;25:407&#x2013;426. doi: 10.1007/s10571-005-3150-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-005-3150-z</ArticleId><ArticleId IdType="pubmed">16047549</ArticleId></ArticleIdList></Reference><Reference><Citation>Mladinic M., Lef&#xe8;vre C., Del Bel E., Nicholls J., Digby M. Developmental changes of gene expression after spinal cord injury in neonatal opossums. Brain Res. 2010;1363:20&#x2013;39. doi: 10.1016/j.brainres.2010.09.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2010.09.024</ArticleId><ArticleId IdType="pubmed">20849836</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaefers A.T.U., Teuchert-Noodt G. Developmental neuroplasticity and the origin of neurodegenerative diseases. World J. Biol. Psychiatry. 2013;17:797104. doi: 10.3109/15622975.2013.797104.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/15622975.2013.797104</ArticleId><ArticleId IdType="pubmed">23705632</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogh I., Ratti A., Gellera C., Lin K., Tiloca C., Moskvina V., Corrado L., Soraru G., Cereda C., Corti S., et al. A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis. Hum. Mol. Genet. 2013;23:2220&#x2013;2231. doi: 10.1093/hmg/ddt587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt587</ArticleId><ArticleId IdType="pmc">PMC3959809</ArticleId><ArticleId IdType="pubmed">24256812</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es M., Veldink J.H., Saris C.G.J., Blauw H.M., Van Vught P.W.J., Birve A., Lemmens R., Schelhaas H.J., Groen E.J., Huisman M.H.B., et al. Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat. Genet. 2009;41:1083&#x2013;1087. doi: 10.1038/ng.442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.442</ArticleId><ArticleId IdType="pubmed">19734901</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenmund C., Sigler A., Augustin I., Reim K., Brose N., Rhee J.-S. Differential Control of Vesicle Priming and Short-Term Plasticity by Munc13 Isoforms. Neuron. 2002;33:411&#x2013;424. doi: 10.1016/S0896-6273(02)00568-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(02)00568-8</ArticleId><ArticleId IdType="pubmed">11832228</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin I., Rosenmund C., S&#xfc;dhof T.C., Brose N. Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles. Nature. 1999;400:457&#x2013;461. doi: 10.1038/22768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/22768</ArticleId><ArticleId IdType="pubmed">10440375</ArticleId></ArticleIdList></Reference><Reference><Citation>Puzzolo E., Mallamaci A. Cortico-cerebral histogenesis in the opossum Monodelphis domestica: Generation of a hexalaminar neocortex in the absence of a basal proliferative compartment. Neural Dev. 2010;5:8. doi: 10.1186/1749-8104-5-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1749-8104-5-8</ArticleId><ArticleId IdType="pmc">PMC2859365</ArticleId><ArticleId IdType="pubmed">20302607</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillaud L., El-Agamy S.E., Otsuki M., Terenzio M. Anterograde Axonal Transport in Neuronal Homeostasis and Disease. Front. Mol. Neurosci. 2020;13:556175. doi: 10.3389/fnmol.2020.556175.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2020.556175</ArticleId><ArticleId IdType="pmc">PMC7531239</ArticleId><ArticleId IdType="pubmed">33071754</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito A., Cavalli V. Signaling Over Distances. Mol. Cell. Proteom. 2016;15:382&#x2013;393. doi: 10.1074/mcp.R115.052753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.R115.052753</ArticleId><ArticleId IdType="pmc">PMC4739662</ArticleId><ArticleId IdType="pubmed">26297514</ArticleId></ArticleIdList></Reference><Reference><Citation>Setou M., Nakagawa T., Seog D.-H., Hirokawa N. Kinesin Superfamily Motor Protein KIF17 and mLin-10 in NMDA Receptor-Containing Vesicle Transport. Science. 2000;288:1796&#x2013;1802. doi: 10.1126/science.288.5472.1796.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.288.5472.1796</ArticleId><ArticleId IdType="pubmed">10846156</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanai Y., Okada Y., Tanaka Y., Harada A., Terada S., Hirokawa N. KIF5C, a Novel Neuronal Kinesin Enriched in Motor Neurons. J. Neurosci. 2000;20:6374&#x2013;6384. doi: 10.1523/JNEUROSCI.20-17-06374.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.20-17-06374.2000</ArticleId><ArticleId IdType="pmc">PMC6772948</ArticleId><ArticleId IdType="pubmed">10964943</ArticleId></ArticleIdList></Reference><Reference><Citation>Buster D.W., Baird D.H., Yu W., Solowska J.M., Chauvi&#xe8;re M., Mazurek A., Kress M., Baas P.W. Expression of the mitotic kinesin Kif15 in postmitotic neurons: Implications for neuronal migration and development. J. Neurocytol. 2003;32:79&#x2013;96. doi: 10.1023/A:1027332432740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1027332432740</ArticleId><ArticleId IdType="pubmed">14618103</ArticleId></ArticleIdList></Reference><Reference><Citation>Seelke A.M., Dooley J.C., Krubitzer L.A. Differential changes in the cellular composition of the developing marsupial brain. J. Comp. Neurol. 2013;521:2602&#x2013;2620. doi: 10.1002/cne.23301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.23301</ArticleId><ArticleId IdType="pmc">PMC3934569</ArticleId><ArticleId IdType="pubmed">23322491</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli E.T., Lasseigne B.N., Petrovski S., Sapp P.C., Dion P.A., Leblond C.S., Couthouis J., Lu Y.-F., Wang Q., Krueger B.J., et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science. 2015;347:1436&#x2013;1441. doi: 10.1126/science.aaa3650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa3650</ArticleId><ArticleId IdType="pmc">PMC4437632</ArticleId><ArticleId IdType="pubmed">25700176</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenna K.P., SLAGEN Consortium. van Doormaal P.T.C., Dekker A.M., Ticozzi N., Kenna B.J., Diekstra F.P., van Rheenen W., van Eijk K.R., Jones A.R., et al. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. Nat. Genet. 2016;48:1037&#x2013;1042. doi: 10.1038/ng.3626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3626</ArticleId><ArticleId IdType="pmc">PMC5560030</ArticleId><ArticleId IdType="pubmed">27455347</ArticleId></ArticleIdList></Reference><Reference><Citation>Fry A.M., O&#x2019;Regan L., Sabir S., Bayliss R. Cell cycle regulation by the NEK family of protein kinases. J. Cell Sci. 2012;125:4423&#x2013;4433. doi: 10.1242/jcs.111195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.111195</ArticleId><ArticleId IdType="pmc">PMC3500863</ArticleId><ArticleId IdType="pubmed">23132929</ArticleId></ArticleIdList></Reference><Reference><Citation>Meirelles G.V., Perez A.M., De Souza E.E., Basei F.L., Papa P.F., Hanchuk T.D.M., Cardoso V.B., Kobarg J. &#x201c;Stop Ne(c)king around&#x201d;: How interactomics contributes to functionally characterize Nek family kinases. World J. Biol. Chem. 2014;5:141&#x2013;160. doi: 10.4331/wjbc.v5.i2.141.</Citation><ArticleIdList><ArticleId IdType="doi">10.4331/wjbc.v5.i2.141</ArticleId><ArticleId IdType="pmc">PMC4050109</ArticleId><ArticleId IdType="pubmed">24921005</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrovi&#x107; A., Ban J., Ivani&#x10d;i&#x107; M., Tomljanovi&#x107; I., Mladinic M. The Role of ATF3 in Neuronal Differentiation and Development of Neuronal Networks in Opossum Postnatal Cortical Cultures. Int. J. Mol. Sci. 2022;23:4964. doi: 10.3390/ijms23094964.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23094964</ArticleId><ArticleId IdType="pmc">PMC9100162</ArticleId><ArticleId IdType="pubmed">35563354</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt D., Raivich G., Anderson P.N. Activating Transcription Factor 3 and the Nervous System. Front. Mol. Neurosci. 2012;5:7. doi: 10.3389/fnmol.2012.00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2012.00007</ArticleId><ArticleId IdType="pmc">PMC3278981</ArticleId><ArticleId IdType="pubmed">22347845</ArticleId></ArticleIdList></Reference><Reference><Citation>Mladinic M., Bianchetti E., Dekanic A., Mazzone G.L., Nistri A. ATF3 is a novel nuclear marker for migrating ependymal stem cells in the rat spinal cord. Stem Cell Res. 2014;12:815&#x2013;827. doi: 10.1016/j.scr.2014.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2014.03.006</ArticleId><ArticleId IdType="pubmed">24801224</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua J.Y., Ng S.J., Yagensky O., Wanker E.E., Chua J.J.E. FEZ1 Forms Complexes with CRMP1 and DCC to Regulate Axon and Dendrite Development. Eneuro. 2021;8:ENEURO.0193-20.2021. doi: 10.1523/ENEURO.0193-20.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/ENEURO.0193-20.2021</ArticleId><ArticleId IdType="pmc">PMC8174033</ArticleId><ArticleId IdType="pubmed">33771901</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe Y., Nakagawa T., Akiyama T., Nakagawa M., Suzuki N., Warita H., Aoki M., Nakayama K. An Amyotrophic Lateral Sclerosis-Associated Mutant of C21ORF2 Is Stabilized by NEK1-Mediated Hyperphosphorylation and the Inability to Bind FBXO3. iScience. 2020;23:101491. doi: 10.1016/j.isci.2020.101491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101491</ArticleId><ArticleId IdType="pmc">PMC7481237</ArticleId><ArticleId IdType="pubmed">32891887</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J.-L., Chang C.-H., Tsai J.-W. Gli2 Rescues Delays in Brain Development Induced by Kif3a Dysfunction. Cereb. Cortex. 2018;29:751&#x2013;764. doi: 10.1093/cercor/bhx356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bhx356</ArticleId><ArticleId IdType="pubmed">29342244</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf6;hme M., Beis C., Reddy-Alla S., Reynolds E., Mampell M.M., Grasskamp A.T., L&#xfc;tzkendorf J., Bergeron D.D., Driller J.H., Babikir H., et al. Active zone scaffolds differentially accumulate Unc13 isoforms to tune Ca2+ channel&#x2013;vesicle coupling. Nat. Neurosci. 2016;19:1311&#x2013;1320. doi: 10.1038/nn.4364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4364</ArticleId><ArticleId IdType="pubmed">27526206</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlocai M.R., Heredi J., Benedek T., Holderith N., Lorincz A., Nusser Z. Variability in the Munc13-1 content of excitatory release sites. eLife. 2021;10:67468. doi: 10.7554/eLife.67468.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.67468</ArticleId><ArticleId IdType="pmc">PMC8116053</ArticleId><ArticleId IdType="pubmed">33904397</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong R.J., A Barker R. Neurodegeneration: A failure of neuroregeneration? Lancet. 2001;358:1174&#x2013;1176. doi: 10.1016/S0140-6736(01)06260-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(01)06260-2</ArticleId><ArticleId IdType="pubmed">11597694</ArticleId></ArticleIdList></Reference><Reference><Citation>Poplawski G.H.D., Kawaguchi R., Van Niekerk E., Lu P., Mehta N., Canete P., Lie R., Dragatsis I., Meves J.M., Zheng B., et al. Injured adult neurons regress to an embryonic transcriptional growth state. Nature. 2020;581:77&#x2013;82. doi: 10.1038/s41586-020-2200-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2200-5</ArticleId><ArticleId IdType="pubmed">32376949</ArticleId></ArticleIdList></Reference><Reference><Citation>Mertens J., Herdy J.R., Traxler L., Schafer S.T., Schlachetzki J.C., B&#xf6;hnke L., Reid D.A., Lee H., Zangwill D., Fernandes D.P., et al. Age-dependent instability of mature neuronal fate in induced neurons from Alzheimer&#x2019;s patients. Cell Stem Cell. 2021;28:1533&#x2013;1548.e6. doi: 10.1016/j.stem.2021.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2021.04.004</ArticleId><ArticleId IdType="pmc">PMC8423435</ArticleId><ArticleId IdType="pubmed">33910058</ArticleId></ArticleIdList></Reference><Reference><Citation>Kisby G.E., Spencer P.S. Genotoxic Damage During Brain Development Presages Prototypical Neurodegenerative Disease. Front. Neurosci. 2021;15:752153. doi: 10.3389/fnins.2021.752153.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.752153</ArticleId><ArticleId IdType="pmc">PMC8675606</ArticleId><ArticleId IdType="pubmed">34924930</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P., Jia Y., Tang W., Cui Q., Liu M., Jiang J. Roles of Non-coding RNAs in Central Nervous System Axon Regeneration. Front. Neurosci. 2021;15:630633. doi: 10.3389/fnins.2021.630633.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.630633</ArticleId><ArticleId IdType="pmc">PMC7882506</ArticleId><ArticleId IdType="pubmed">33597844</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Liu H., Zhang Q., Zhang Y. The functions of long non-coding RNAs in neural stem cell proliferation and differentiation. Cell Biosci. 2020;10:1&#x2013;10. doi: 10.1186/s13578-020-00435-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-020-00435-x</ArticleId><ArticleId IdType="pmc">PMC7260844</ArticleId><ArticleId IdType="pubmed">32514332</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Anca M., Buccellato F.R., Fenoglio C., Galimberti D. Circular RNAs: Emblematic Players of Neurogenesis and Neurodegeneration. Int. J. Mol. Sci. 2022;23:4134. doi: 10.3390/ijms23084134.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23084134</ArticleId><ArticleId IdType="pmc">PMC9032451</ArticleId><ArticleId IdType="pubmed">35456950</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy B., Lee E., Li T., Rampersaud M. Role of miRNAs in Neurodegeneration: From Disease Cause to Tools of Biomarker Discovery and Therapeutics. Genes. 2022;13:425. doi: 10.3390/genes13030425.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes13030425</ArticleId><ArticleId IdType="pmc">PMC8951370</ArticleId><ArticleId IdType="pubmed">35327979</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y., Yin Y., Xiao Z., Zhao Y., Chen B., Yang B., Xu B., Song H., Zou Y., Ma X., et al. LncRNA Neat1 mediates miR-124-induced activation of Wnt/&#x3b2;-catenin signaling in spinal cord neural progenitor cells. Stem Cell Res. Ther. 2019;10:1&#x2013;11. doi: 10.1186/s13287-019-1487-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-019-1487-3</ArticleId><ArticleId IdType="pmc">PMC6921476</ArticleId><ArticleId IdType="pubmed">31852544</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang E.-M., Jia Y.-B., Wang J.-Y., Wang G.-Y., Chen H.-J., Chen X.-Y., Ye Y.-Q., Zhang X., Su X.-H., Wang J.-Y., et al. Downregulation of MicroRNA-124-3p Promotes Subventricular Zone Neural Stem Cell Activation by Enhancing the Function of BDNF Downstream Pathways after Traumatic Brain Injury in Adult Rats. CNS Neurosci. Ther. 2022;28:1081&#x2013;1092. doi: 10.1111/cns.13845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.13845</ArticleId><ArticleId IdType="pmc">PMC9160452</ArticleId><ArticleId IdType="pubmed">35481944</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker S.E., Sabin K.Z., Gearhart M.D., Yamamoto K., Echeverri K. Regulation of stem cell identity by miR-200a during spinal cord regeneration. Development. 2022;149:200033. doi: 10.1242/dev.200033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.200033</ArticleId><ArticleId IdType="pmc">PMC8918811</ArticleId><ArticleId IdType="pubmed">35156681</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y.-P., Yang Y.-D., Mou F.-F., Zhu J., Li H., Zhao T.-T., Zhao Y., Shao S.-J., Cui G.-H., Guo H.-D. Exosome-Mediated miR-21 Was Involved in the Promotion of Structural and Functional Recovery Effect Produced by Electroacupuncture in Sciatic Nerve Injury. Oxidative Med. Cell. Longev. 2022;2022:7530102. doi: 10.1155/2022/7530102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/7530102</ArticleId><ArticleId IdType="pmc">PMC8817850</ArticleId><ArticleId IdType="pubmed">35132352</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z., Meng Z., Zhao Z. Silk fibroin nanofibrous scaffolds incorporated with microRNA-222 loaded chitosan nanoparticles for enhanced neuronal differentiation of neural stem cells. Carbohydr. Polym. 2021;277:118791. doi: 10.1016/j.carbpol.2021.118791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carbpol.2021.118791</ArticleId><ArticleId IdType="pubmed">34893221</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen K., Ding L., Shui H., Liang Y., Zhang X., Wang T., Li L., Liu S., Wu H. MiR-615 Agomir Encapsulated in Pluronic F-127 Alleviates Neuron Damage and Facilitates Function Recovery After Brachial Plexus Avulsion. J. Mol. Neurosci. 2021;72:136&#x2013;148. doi: 10.1007/s12031-021-01916-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-021-01916-5</ArticleId><ArticleId IdType="pmc">PMC8755699</ArticleId><ArticleId IdType="pubmed">34569008</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H., Ding L., Wang Y., Zou T.-B., Wang T., Fu W., Lin Y., Zhang X., Chen K., Lei Y., et al. MiR-615 Regulates NSC Differentiation In Vitro and Contributes to Spinal Cord Injury Repair by Targeting LINGO-1. Mol. Neurobiol. 2020;57:3057&#x2013;3074. doi: 10.1007/s12035-020-01936-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-020-01936-z</ArticleId><ArticleId IdType="pubmed">32462552</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L., Gong L., Li P., Qin J., Xu L., Wei Q., Xie H., Mao S., Yu B., Gu X., et al. miR-20a Promotes the Axon Regeneration of DRG Neurons by Targeting Nr4a. Neurosci. Bull. 2021;37:569&#x2013;574. doi: 10.1007/s12264-021-00647-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12264-021-00647-2</ArticleId><ArticleId IdType="pmc">PMC8055734</ArticleId><ArticleId IdType="pubmed">33683649</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning X.-J., Lu X.-H., Luo J.-C., Chen C., Gao Q., Li Z.-Y., Wang H. Molecular mechanism of microRNA-21 promoting Schwann cell proliferation and axon regeneration during injured nerve repair. RNA Biol. 2020;17:1508&#x2013;1519. doi: 10.1080/15476286.2020.1777767.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2020.1777767</ArticleId><ArticleId IdType="pmc">PMC7549677</ArticleId><ArticleId IdType="pubmed">32507001</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornelis G., Souquere S., Vernochet C., Heidmann T., Pierron G. Functional conservation of the lncRNA NEAT1 in the ancestrally diverged marsupial lineage: Evidence for NEAT1 expression and associated paraspeckle assembly during late gestation in the opossum Monodelphis domestica. RNA Biol. 2016;13:826&#x2013;836. doi: 10.1080/15476286.2016.1197482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2016.1197482</ArticleId><ArticleId IdType="pmc">PMC5014006</ArticleId><ArticleId IdType="pubmed">27315396</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., Amin N., Schwikowski B., Ideker T. Cytoscape: A software environment for integrated models of Biomolecular Interaction Networks. Genome Res. 2003;13:2498&#x2013;2504. doi: 10.1101/gr.1239303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.1239303</ArticleId><ArticleId IdType="pmc">PMC403769</ArticleId><ArticleId IdType="pubmed">14597658</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>